Bayer HealthCare


  • Feb
    10
    By RAKESH KHAR

    THE Delhi High Court has dismissed an appeal by Bayer Corporation, an MNC drug firm, seeking to stop the Drug Controller of India (DCGI) from granting marketing approval to Cipla